The sale of a business unit often leads to a short-term increase in a company's stock price, as it can be seen as a sign of strategic focus and potential for increased profitability. In this case, Elutia's stock price has increased following the announcement of the sale of its Orthobiologics business unit to Berkeley Biologics LLC.